SLC22A18 gene – Talk Bio

Actionable Insights Powered by AI

ITM Secures Exclusive Global License for Debiopharm’s CA IX-Targeted Theranostic Pair

7 months ago talkbio0Tagged CA9 gene, Debiopharm, Malignant Neoplasms, Radiopharmaceuticals, SLC22A18 gene, Solid Neoplasm, Theranostic Pair

ITM, Debiopharm, CA IX, Theranostic Pair, Radiopharmaceutical, Solid Tumors, Cancer Treatment

ITM Secures €188 Million to Enhance Radiopharmaceutical Pipeline and Strengthen Medical Radioisotope Manufacturing

11 months ago talkbio0Tagged actinium-225, Authority, BlackRock, cancer pipeline, Gastro-enteropancreatic neuroendocrine tumor, Investments, Isotopes, medical radioisotopes, Munich, Qatar, Radiopharmaceuticals, SLC22A18 gene, Technology, Temasek

ITM Isotope Technologies Munich, radiopharmaceutical biotech, Temasek, BlackRock, Qatar Investment Authority, medical radioisotopes, Lutetium-177, Actinium-225, cancer pipeline, gastroenteropancreatic neuroendocrine tumors (GEP-NETs)